The excimer laser: Science fiction fantasy or practical tool?

Journal of Endovascular Therapy

Volumn 11, Issue SUPPL. 2, 2004, Pages

  Biamino, Giancarlo ^a,b  

^a UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angioplasty; Atherectomy; Critical limb ischemia; Excimer laser

Indexed keywords

ANGIOPLASTY; ATHERECTOMY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; EXCIMER LASER; HUMAN; LIMB ISCHEMIA; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SAPHENOUS VEIN GRAFT; TECHNOLOGY; THROMBOSIS; TISSUE INTERACTION;

EID: 12144272050     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1177/15266028040110s622     Document Type: Review

References (69)

1. Choy DS. History of lasers in medicine. Thorac Cardiovasc Surg. 1988;36(Suppl 2):114-117.
2. Bittl JA. Clinical results with excimer laser coronary angioplasty. Semin Interv Cardiol. 1996;1:129-134.
3. Litvack F, Eigler N, Margolis J, et al. Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3000 patients. The ELCA Investigators. J Am Coll Cardiol. 1994;23:323-329.
4. Topaz O, Mclvor M, de Marchena E. Solid-state, pulsed-wave, mid-infrared coronary laser angioplasty in de novo versus restenosis lesions: observations from a multicenter study. J Clin Laser Med Surg. 1995;13:319-323.
5. Reifart N, Vandormael M, Krajcar M, et al. Randomized comparison of angioplasty of complex coronary lesions at a single center, Excimer Laser, Rotational Atherectomy and Balloon Angioplasty Comparison (ERBAC) Study. Circulation. 1997;96:91-98.
6. Appelman YE, Piek JJ, Strikwerda S, et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet. 1996;347:79-84.
7. Oraevsky AA, Jacques SL, Pettit GH, et al. XeCl laser ablation of atherosclerotic aorta: optical properties and energy pathways. Lasers Surg Med. 1992;12:585-597.
8. Geschwind HJ, Boussignac G, Teisseire B, et al. Conditions for effective Nd-YAG laser angioplasty. Br Heart J. 1984;52:484-489.
9. Choy DS, Stertzer SH, Myler RK, et al. Human coronary laser recanalization. Clin Cardiol. 1984;7:377-381.
10. Isner JM, Clarke RH, Donaldson RF, et al. Identification of photoproducts liberated by in vitro argon laser irradiation of atherosclerotic plaque, calcified cardiac valves and myocardium. Am J Cardiol. 1985;55:1192-1196.
11. Abela GS, Crea F, Smith W, et al. In vitro effects of argon laser radiation on blood: quantitative and morphologic analysis. J Am Coll Cardiol. 1985;5:231-237.
12. th ed. Philadelphia: Saunders; 2003:675-703.
13. Grundfest WS, Segalowitz J, Laudenslager J, et al. The physical and biological basis for laser angioplasty. In: Litvack F, ed. Coronary Laser Angioplasty. Oxford: Blackwell Scientific Publications; 1992:1-12.
14. Topaz O. Plaque removal and thrombus dissolution with the photoacoustic energy of pulsed-wave laser: biotissue interactions and their clinical manifestations. Cardiology. 1996;87:384-391.
15. Grundfest WS, Litvack F, Forrester J, et al. Laser ablation of human atherosclerotic plaque without adjacent tissue injury. J Am Coll Cardiol. 1985;5:929-933.
16. Topaz O, Das T, Dahm J, et al. Excimer laser revascularization: current indications, applications and techniques. Laser Med Sci. 2001;16:72-77.
17. Lammer J, Pilger E, Decrinis M, et. al. Pulsed excimer laser versus continuous-wave Nd:YAG laser versus conventional angioplasty of peripheral arterial occlusions: prospective, controlled, randomised trial. Lancet. 1992;340:1183-1188.
18. nd ed. Mount Kisco, NY: Futura Publishing Company; 1992.
19. Taylor K, Reiser C. Next generation catheters for excimer laser coronary angioplasty. Lasers Med Sci. 2001;16:133-140.
20. Van Leeuwen TG, Meertens JH, Velema E, et al. Intraluminal vapor bubble induced by excimer laser pulse causes microsecond arterial dilation and invagination leading to extensive wall damage in the rabbit. Circulation. 1993;87:1258-1263.
21. Isner JM, Pickering JG, Mosseri M. Laser-induced dissections: pathogenesis and implications for therapy. J Am Coll Cardiol. 1992;19:1619-1621.
22. Tcheng JE. Saline infusion in excimer laser coronary angioplasty. Semin Interv Cardiol. 1996;1:135-141.
23. Tcheng JE, Wells LD, Phillips HR, et al. Development of a new technique for reducing pressure pulse generation during 308-nm excimer laser coronary angioplasty. Cathet Cardiovasc Diagn. 1995;34:15-22.
24. Esenaliev RO, Oraevsky AA, Letokhov VS, et al. Studies of acoustical and shock waves in the pulsed laser ablation of biotissue. Lasers Surg Med. 1993;13:470-484.
25. Deckelbaum Ll, Natarajan MK, Bittl JA. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: a randomized trial. The Percutaneous Excimer Laser Angioplasty (PELCA) Investigators. J Am Coll Cardiol. 1995;26:1264-1269.
26. Topaz O. A new, safer lasing technique for laser-facilitated coronary angioplasty. J Interv Cardiol. 1993;6:297-306.
27. Mehran R, Mintz GS, Satler LF, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. Circulation. 1997;96:2183-2189.
28. Bejarano J, Bermudez E, Diaz P, et al. In-stent restenosis. Acute and long-term outcomes after excimer laser coronary angioplasty. Arq Bras Cardiol. 1999;73:149-156.
29. Hamburger JN, Foley DP, de Feyter PJ, et al. Six-month outcome after excimer laser coronary angioplasty for diffuse in-stent restenosis in native coronary arteries. Am J Cardiol. 2000;86:390-394.
30. Köster R, Kähler J, Terres W, et al. Six-month clinical and angiographic outcome after successful excimer laser angioplasty for in-stent restenosis. J Am Coll Cardiol. 2000;36:69-74.
31. Köster R, Hamm CW, Seabra-Gomes R, et al. Laser angioplasty of restenosed coronary stents: results of a multicenter surveillance trial. The Laser Angioplasty of Restenosed Stents (LARS) Investigators. J Am Coll Cardiol. 1999;34:25-32.
32. Dahm JB, Kuon E, Vogelgesang D, et al. Relation of degree of laser debulking of in-stent restenosis as a predictor of restenosis rate. Am J Cardiol. 2002;90:68-70.
33. Dahm JB, Kuonz E. High-energy eccentric excimer laser angioplasty for debulking diffuse in-stent restenosis leads to better acute and 6-month follow-up results. J Invasive Cardiol. 2000;12:335-342.
34. Steinkamp HJ, Werk M, Haufe M, et al. Laser angioplasty of peripheral arteries after unsuccessful recanalization of the superficial femoral artery. Int J Cardiovasc. 2000;3:153-160.
35. White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinical tool. Circulation. 1996;93:253-258.
36. Abela GS, Hage-Korban E, Tomaru T, et al. A model for evaluation of arterial thrombosis following interventional procedures. Lasers Med Sci. 2001;16:141-147.
37. Topaz O, Morris C, Minisi AJ, et al. Enhancement of t-PA induced fibrinolysis with laser energy: in-vitro observations. Lasers Med Sci. 1999;14:123-128.
38. Topaz O, Minisi A, Bernardo N, et al. Alterations of platelet aggregation kinetics with ultraviolet laser emission: the "stunned platelet" phenomenon. Thromb Haemost. 2001;86:1087-1093.
39. Topaz O, Ebersole D, Das T, et al. Excimer laser angioplasty in acute myocardial infarction (the CARMEL multicenter trial). Am J Cardiol. 2004;93:694-701.
40. Webb JG, Carere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol. 1999;34:468-475.
41. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Saphenous vein graft Angioplasty Free of Emboli Randomized (SAFER) Trial Investigators. Circulation. 2002;105:1285-1290.
42. Bittl JA, Sanborn TA, Yardley DE, et al. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein by-pass graft lesions. The Percutaneous Excimer Laser Coronary Angioplasty Registry. Am J Cardiol. 1994;74:144-148.
43. Ebersole D, Dahm JB, Das T, et al. Excimer laser revascularization of saphenous vein grafts in acute myocardial infarction. J Invasive Cardiol. 2004;16:177-180.
44. Bilodeau L, Fretz EB, Taeymany Y, et al. Novel use of a high-energy excimer laser catheter for calcified and complex coronary artery lesions. Catheter Cardiovasc Interv. 2004;62:155-161.
45. Abela GS. Laser arterial recanalization: a current perspective. J Am Coll Cardiol. 1998;12:103-105.
46. Deckelbaum LI, Isner JM, Donaldson R, et al. Reduction of laser-induced pathologic tissue injury using pulsed energy delivery. Am J Cardiol. 1985;56:662-667.
47. Grundfest WS, Litvack IF, Goldenberg T, et al. Pulsed ultraviolet lasers and the potential for safe laser angioplasty. Am J Surg. 1985;150:220-226.
48. Isner JM, Donaldson RF, Deckelbaum LI, et al. The excimer laser: gross, light microscopic and ultrastructural analysis of potential advantages for use in laser therapy of cardiovascular disease. J Am Coll Cardiol. 1985;6:1102-1109.
49. Bonn D. Laser thrombolysis: safe and rapid removal of clots? Lancet. 2000;355:1976.
50. Scheinen D, Laird JRJr, Schröder M, et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther. 2001;8:156-166.
51. Biamino G, Scheinen D. Excimer laser treatment of SFA occlusions. Endovascular Today. 2003;2:45-47.
52. Laird JR. Peripheral Excimer Laser Angioplasty (PELA) trial results. Presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference; September 24-28, 2002; Washington, DC, USA.
53. Haimovici H. Patterns of arteriosclerotic lesions of the lower extremity. Arch Surg. 1967;95:918-933.
54. Mavor GE. The pattern of occlusion in atheroma of the lower limb arteries: the correlation of clinical and arteriographic findings. Br J Surg. 1956;43:352-364.
55. ICAI Study Group. Prostanoids for chronic critical leg ischemia. A randomized, controlled, open-label trial with prostaglandin E1. Ann Intern Med. 1999;130:412-421.
56. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD) TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
57. Gray BH, Laird JR, Ansel GM, et al. Complex endovascular treatment for critical limb ischemia in poor surgical candidates: a pilot study. J Endovasc Ther. 2002;9:599-604.
58. Holdsworth J. District hospital management and outcome of critical lower limb ischaemia: comparison with national figures. Eur J Vasc Endovasc Surg. 1997;13:159-163.
59. A prospective epidemiological survey of the natural history of chronic critical leg ischaemia. The I.C.A.I. Group (gruppo di studio dell'ischemia cronica critica degli arti inferiori). Eur J Vasc Endovasc Surg. 1996;11:112-120.
60. Laird JR, Reiser C, Biamino G, et al. Excimer laser assisted angioplasty for the treatment of critical limb ischemia. J Cardiovasc Surg (Torino). 2004;45:239-248.
61. Pagan A. The LACI Trial: 6-month results. Endovascular Today. 2003;2:17-21.
62. Zeller T, Scheinen D. Laser angioplasty for critical limb ischemia. Endovascular Today. 2004;3:63-65.
63. Allie DE, Heben CJ, Lirtzman CH, et al. Infrapopliteal excimer laser-assisted angioplasty in "true limb salvage": a 12-month LACI equivalent study. Poster abstract presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference; September 15-19, 2003; Washington, DC, USA.
64. Peeters P, Bosiers M. Laser revascularization of below the knee lesions. Presented at the Belgian Society for Vascular Surgery (BSVS) Meeting; April 2004; Brussels, Belgium.
65. Soder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol. 2000;11:1021-1031.
66. Lofberg AM, Lorelius LE, Karacagil S, et al. The use of below-knee percutaneous transluminal angioplasty in arterial occlusive disease causing chronic critical limb ischemia. Cardiovasc Intervent Radiol. 1996;19:317-322.
67. Matsi PJ, Manninen HI, Laakso M, et al. Impact of risk factors on limb salvage after angioplasty in chronic critical lower limb ischemia. A prospective trial. Angiology. 1994;45:797-804.
68. Danielsson G, Albrechtsson U, Norgren L, et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg. 2001;21:432-436.
69. Dorros G, Jaff MR, Dorros AM, et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation. 2001;104:2057-2062.